Metraipolis › archive › dc_4497b13ee4dd
Rosuvastatin Versus Atorvastatin for Cardiovascular Disease Risk in Patients with Type 2 Diabetes: A Korean Cohort Study — Europe PMC PMID:41471348
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41471348
- DOI
- 10.3390/ph18121860
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:36:38.499Z
- SHA-256 of the archived text
fc3bf455765d7f91dde500fd550465051955a2b73f8743094be95cf4da56c10c- Stable URL of this page
https://metraipolis.com/documento/dc_4497b13ee4dd
How to cite
Rosuvastatin Versus Atorvastatin for Cardiovascular Disease Risk in Patients with Type 2 Diabetes: A Korean Cohort Study — Europe PMC PMID:41471348 — Europe PMC (en), https://europepmc.org/article/MED/41471348 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4497b13ee4dd (Metraipolis archive dc_4497b13ee4dd, sha256 fc3bf455765d7f91dde500fd550465051955a2b73f8743094be95cf4da56c10c)
BibTeX
@misc{dc4497b13ee4dd,
title = {Rosuvastatin Versus Atorvastatin for Cardiovascular Disease Risk in Patients with Type 2 Diabetes: A Korean Cohort Study — Europe PMC PMID:41471348},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41471348},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4497b13ee4dd; sha256 fc3bf455765d7f91dde500fd550465051955a2b73f8743094be95cf4da56c10c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471348. Agents can read the archived copy with the MCP tool read_document.